Kathleen LaPorte

Concentrates on our pharmaceutical companies. Kathy joined the Sprout Group in 1993 and became a General Partner in 1994. Between 1987 and 1993, she was a Principal at Asset Management Company, a venture capital firm focused on early stage investments. Previously, she was a financial analyst with The First Boston Corporation. Ms. LaPorte's focus is on biopharmaceutical and diagnostic investments. She is the Past President, and a former member of the Board of the Western Association of Venture Capitalists. Ms. LaPorte received an M.B.A. from Stanford University Graduate School of Business (Arjay Miller Scholar), and a B.S., summa cum laude, Phi Beta Kappa from Yale University.